PYC Therapeutics Limited - Making Sense of the PPMO-CPP Combination
Initiating on PYC Therapeutics with a BUY rating and risked price target of $0.22. PYC is a clinical stage biotechnology company in the gene...
218 Views
Australian Biotech Companies Amid Talk of Likely Interest Rate Cut
RBA keeps interest rates steady at 4.35%, while economists predict possible cut to 4.10% in 4Q24. Australian biotech companies should be in focus...
291 Views
Aussie Healthcare Daily: 4 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
302 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
5.8k Views